Hesperidin是在柑橘类水果中广泛存在的黄酮苷。
Hesperidin is a flavanone glycoside found abundantly in citrus fruits.
动物 A (mg/kg) = 动物 B (mg/kg)×动物 B的Km系数/动物 A的Km系数 | |
例如,已知某工具药用于小鼠的剂量为88 mg/kg , 则用于大鼠的剂量换算方法:将88 mg/kg 乘以小鼠的Km系数(3),再除以大鼠的Km系数(6),得到该药物用于大鼠的等效剂量44 mg/kg。
[1] Yang, M., et al., 1997. Chemopreventive effects of diosmin and hesperidin on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary-bladder carcinogenesis in male ICR mice. International journal of cancer. Journal international du cancer. 73(5): 719-24. PMID: 9398052
[2] Tanaka, T., et al., 1997. Chemoprevention of azoxymethane-induced rat colon carcinogenesis by the naturally occurring flavonoids, diosmin and hesperidin. Carcinogenesis. 18(5): 957-65. PMID: 9163681
[3] Tanaka, T., et al., 1997. Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis in rats by flavonoids diosmin and hesperidin, each alone and in combination. Cancer research. 57(2): 246-52. PMID: 9000563
[4] Wanpeng Xi et. Al. Food Chemistry, 161, 230-238 (2014).
[5] George Man et. Al. Experimental Dermatology, 23(9), 645-651 (2014).
[6] Otilia J F Banji et. Al. Food and Chemical Toxicology, 74, 51-59 (2014).
分子式 C28H34O15 |
分子量 610.56 |
CAS号 520-26-3 |
储存方式 ﹣20 ℃冷藏长期储存。冰袋运输 |
溶剂(常温) |
DMSO 122 mg/mL |
Water <1 mg/mL |
Ethanol <1 mg/mL |
体内溶解度
NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated |
NCT01881204 | Osteoporosis, Postmenopausal | Dietary Supplement: Hesperidin and Calcilock|Dietary Supplement: Hesperidin|Dietary Supplement: Control | Purdue University|Nestec Ltd. | 2011-04-01 | 2013-06-17 | |
NCT00914251 | Endothelial Dysfunction|Metabolic Syndrome | Drug: Hesperidin|Drug: Placebo | University of Rome Tor Vergata | Phase 2 | 2008-11-01 | 2009-06-16 |
NCT01773486 | Obesity|Insulin Resistance | Drug: Hesperidin|Drug: Placebo | University of Maryland | Phase 2 | 2015-06-01 | 2016-01-28 |
NCT00545116 | Osteopenia|Osteoporosis | Other: Hesperidin | Nestl|National University of Malaysia | Phase 2 | 2007-10-01 | 2015-10-05 |
NCT02610491 | Metabolic Syndrome|Obesity | Dietary Supplement: Hesperidin|Dietary Supplement: Placebo | Maastricht University Medical Center | Phase 2 | 2015-02-01 | 2015-11-19 |
NCT02927483 | Chronic Venous Insufficiency | Dietary Supplement: Endolex Forte|Dietary Supplement: A combination of diosmin and hesperidin | SunWave Pharma|Opera Contract Research Organization SRL | Phase 3 | 2016-11-01 | 2016-10-27 |
NCT00330096 | Osteoporosis, Osteopenia | Drug: Hesperidin|Other: Placebo | Nestl|Institut National de la Recherche Agronomique|Centre de Recherche en Nutrition Humaine. Clermont-Ferrand, France | Phase 3 | 2006-03-01 | 2015-10-28 |
NCT02479568 | Cardiovascular Risk Factors | Dietary Supplement: Control|Dietary Supplement: 100% Florida OJ|Dietary Supplement: 100% Florida OJ-enriched | Technological Centre of Nutrition and Health, Spain|Florida Department of Citrus|Technological Centre of Nutrition and Health|Hospital Universitari Sant Joan de Reus|University Rovira i Virgili | Phase 3 | 2015-09-01 | 2016-06-03 |
NCT02907320 | Venous Disease Classification (CEAP): C2 or C3 | Drug: CYCLO 3 FORT|Drug: MPFF|Drug: placebo CYCLO 3 FORT|Drug: placebo MPFF | Pierre Fabre Medicament|Eurotrials Brasil Consultores Cientificos Ltda | Phase 2 | 2016-12-01 | 2017-02-17 |
NCT01110512 | Venous Insufficiency | Drug: Flavonid|Drug: Daflon | Azidus Brasil | Phase 3 | 2010-10-01 | 2010-10-26 |
NCT01477281 | Chronic Venous Insufficiency|Disease | Drug: Daflon|Drug: Venaflon (Diosmin and Hesperidin) | Laboratrio Teuto Brasileiro S/A | Phase 3 | 2012-02-01 | 2011-11-18 |
NCT02380144 | Healthy | Other: Fresh orange fruit and pasteurized fruit juice | University of Hohenheim | 2014-01-01 | 2016-10-30 |
注:以上所有数据均来自公开文献,并不保证对所有实验均有效,数据仅供参考。
相关化合物库
使用AMQUAR产品发表文献后请联系我们